# The Effectiveness of Gabapentin for Post-operative Pain Following Cesarean Section

> **NCT01094925** · NA · COMPLETED · sponsor: **Samuel Lunenfeld Research Institute, Mount Sinai Hospital** · enrollment: 126 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** lactose
- **DRUG:** Gabapentin 300mg
- **DRUG:** Gabapentin 600mg

## Key facts

- **NCT ID:** NCT01094925
- **Lead sponsor:** Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-12
- **Final completion:** 2011-02
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2011-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01094925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01094925, "The Effectiveness of Gabapentin for Post-operative Pain Following Cesarean Section". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01094925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*